| Literature DB >> 32354785 |
Peter Hangoma1, Maio Bulawayo2, Mwimba Chewe2, Nicholas Stacey3, Laura Downey4,5, Kalipso Chalkidou5,6, Karen Hofman3, Mpuma Kamanga7, Anita Kaluba7, Gavin Surgey3,8.
Abstract
The global burden of non-communicable diseases (NCDs) has been rising. A key risk factor for NCDs is obesity, which has been partly linked to consumption of sugar sweetened beverages (SSBs). A tax on SSBs is an attractive control measure to curb the rising trend in NCDs, as it has the potential to reduce consumption of SSBs. However, studies on the potential effects of SSB taxes have been concentrated in high-income countries with limited studies in low-income and middle-income countries. Using data from the 2015 Zambia Living Conditions Monitoring Survey (LCMS) data, the 2017 Zambia NCD STEPS Survey, and key parameters from the literature, we simulated the effect of a 25% SSB tax in Zambia on energy intake and the corresponding change in body mass index (BMI), obesity prevalence, deaths averted, life years gained and revenues generated using a mathematical model developed using Microsoft Excel. We conducted Monte Carlo simulations to construct 95% confidence bands and sensitivity analyses to account for uncertainties in key parameters. We found that a 25% SSB would avert 2526 deaths, though these results were not statistically significant overall. However, when broken down by gender, the tax was found to significantly avert 1133 deaths in women (95% CI 353 to 1970). The tax was found to potentially generate an additional US$5.46 million (95% CI 4.66 to 6.14) in revenue annually. We conclude that an SSB tax in Zambia has the potential to significantly decrease the amount of disability-adjusted life years lost to lifestyle-related diseases in women, highlighting important health equity outcomes. Women have higher baseline BMI and therefore are at higher risk for NCDs. In addition, an SSB tax will provide government with additional revenue which if earmarked for health could contribute to healthcare financing in Zambia. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.Entities:
Keywords: health economics; health policy; public health
Mesh:
Year: 2020 PMID: 32354785 PMCID: PMC7213810 DOI: 10.1136/bmjgh-2019-001968
Source DB: PubMed Journal: BMJ Glob Health ISSN: 2059-7908
Data sources
| Parameter/variable | Best estimate | Source |
| BMI (kg/m2) | 23.38 | Zambia STEPS Survey 2017 |
| Average weekly consumption of sugary drinks (300 mL servings) | 1.55 | Zambia Living Conditions and Monitoring Survey (LCMS) 2015 |
| Average price of sugary drinks (per 300 mL serving) | ZMW 3.77 (or US$0.40) | Zambia Central Statistics Office |
| Average all-cause mortality rate (per 100 000 population) | 30.1 | Zambia Central Statistics Office |
| Potential impact fractions (PIF) (1+ PIF) | 0.0001 (1.0001) | Manyema |
| Own-price elasticities for SSBs | −1.30 (95% CI −1.10 to –1.51) | Meta-analysis |
| Cross-price elasticities | 0.32 (95% CI 0.01 to 0.77) for fruit juice, and 0.18 (95% CI −0.10 to 0.34) for milk. | Escobar |
| 100% (80%–120%) | Crawford |
BMI, body mass index; CI, confidence interval; SSB, sugar sweetened beverage; STEPS, STEPwise approach to noncommunicable disease risk factor surveillance; ZMW, Zambian Kwacha.
Figure 1Model simulation structure.
Weekly per capita beverage consumption by sex and age groups
| Age, years | Average weekly consumption of 300 mL servings | ||
| SSB | Fruit juice | Milk | |
| Male | |||
| 15–24 | 1.77 | 1.47 | 0.98 |
| 25–34 | 2.17 | 1.32 | 1.21 |
| 35–44 | 2.05 | 1.30 | 1.31 |
| 45–54 | 1.82 | 1.12 | 1.28 |
| 55–64 | 1.52 | 1.11 | 1.27 |
| 65+ | 1.21 | 1.22 | 1.30 |
| Female | |||
| 15–24 | 1.71 | 0.79 | 1.01 |
| 25–34 | 1.73 | 1.52 | 1.15 |
| 35–44 | 1.70 | 1.52 | 1.31 |
| 45–54 | 1.61 | 1.46 | 1.29 |
| 55–64 | 1.30 | 1.30 | 1.21 |
| 65+ | 0.93 | 1.20 | 1.25 |
SSB, sugar sweetened beverage.
Figure 2Impact on consumption of sugary drinks.
Figure 3Effect of a 25% sugar tax on obesity prevalence. BMI, body mass index.
Deaths averted and life years gained
| Mean | 95% lower bound | 95% upper bound | |
| Deaths averted | |||
| Male | 1 to 393 | −2 to 912 | 5 to 694 |
| Female | 1 to 133 | 353 | 1 to 970 |
| Total | − | ||
| Life years gained | |||
| Male | 7 to 930 | −19 to 366 | 34 to 786 |
| Female | 6 to 824 | 2 to 006 | 11 to 910 |
| Total | − | ||
Effect of varying tax and pass-on rates on health effects
| Tax rate | ||||
| 15% | 20% | 25% | ||
| Pass-on rate | 80% | 6 to 345 | 8 to 777 | 9 to 921 |
| 90% | 7 to 339 | 9 to 514 | 12 to 415 | |
| 100% | 7 to 731 | 9 to 921 | 14 to 755 | |
| Pass-on rate | 80% | 1 to 100 | 1 to 510 | 1 to 722 |
| 90% | 1 to 262 | 1 to 642 | 2 to 133 | |
| 100% | 1 to 335 | 1 to 722 | 2 to 526 | |
Annual tax revenue generated, US$ million
| Mean | 95% lower bound | 95% upper bound | |
| Excise revenue | 5.99 | 5.58 | 6.35 |
| VAT revenue | −0.53 | −0.92 | −0.14 |
| Total | 5.46 | 4.66 | 6.14 |
N/A, N/A; VAT, value added tax.